Effect of Inhalation Sedation Compared With Propofol on the Sepsis-related Acute Respiratory Distress Syndrome Course

NCT04014218 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2019-07-10

No results posted yet for this study

Summary

Investigation of effect of inhalation sedation by administration of Sevoflurane compared with Propofol on the moderate acute respiratory distress syndrome course in mechanically ventilated patients with sepsis.

Conditions

  • ARDS

Interventions

DRUG

Inhalation Sedation

Inhalation Sedation by Administration of Sevoflurane

DRUG

Intravenous Sedation

Intravenous Sedation by Administration of Propofol

Sponsors & Collaborators

  • I.M. Sechenov First Moscow State Medical University

    collaborator OTHER
  • Moscow Regional Research and Clinical Institute (MONIKI)

    lead OTHER_GOV

Principal Investigators

  • Valery V Likhvantsev, · Moscow Regional Clinical and Research Institute, Department of Intensive Care

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-01-08
Primary Completion
2019-09-30
Completion
2020-01-31

Countries

  • Russia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04014218 on ClinicalTrials.gov